Research report
The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis

https://doi.org/10.1016/0166-4328(95)00162-XGet rights and content

Abstract

Phencyclidine (PCP) produces a psychotic reaction in humans which closely resembles an acute episode of schizophrenia and has therefore been given an increasing amount of attention as a model for schizophrenia. The present article reviews the behavioral and neurochemical effects of PCP in both humans and animals. Where possible, comparisons are made between the effects of PCP and amphetamine. The merits of the dopamine versus NMDA/PCP receptor mediated expression of PCP-induced psychosis are discussed, as well as the importance of selecting behavioral models which are best suited to model the expression of psychosis, rather than the motor effects of psychotomimetics.

References (195)

  • B.A. Flint et al.

    Tolerance development to phencyclidine by chronic administration

    Progr. Neuropsychopharmacol.

    (1980)
  • E.D. French

    Effects of N-allynormetazocine (SKF 10,047), phencyclidine and other psychomotor stimulants in the rat following 6-hydroxydopamine lesion of the ventral tegmental area

    Neuropharmacology

    (1986)
  • E.D. French et al.

    Non-competitive N-methyl-d-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons

    Neurosci. Lett.

    (1990)
  • E.D. French et al.

    Effects of competitive N-methyl-d-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine

    Neuropharmacology

    (1991)
  • R.E. Garey et al.

    Effects of phencyclidine on the uptake of 3H catecholamines by rat striatal and hypothalamic synaptosomes

    Life Sci.

    (1976)
  • G. Gianutsos et al.

    Pharmacological changes induced by repeated exposure to phenylethylamine

    Pharmacol. Biochem. Behav.

    (1986)
  • D. Glovinsky et al.

    Early antipsychotic response to resumption of neuroleptics in drug-free chronic schizophrenic patients

    Biol. Psychiatry

    (1992)
  • K.M. Johnson et al.

    The effects of phencyclidine on dopamine metabolism in the mouse brain

    Life Sci.

    (1981)
  • M. Johnstone et al.

    Sernyl (CI-395) in clinical anaesthesia

    Br. J. Anaesth.

    (1959)
  • S. Kaneno et al.

    Decreased in vivo [3H]spiroperidol binding in rat brain after repeated methamphetamine administration

    Eur. J. Pharmacol.

    (1981)
  • V.A. Keith et al.

    Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle

    Biol. Psychiatry

    (1991)
  • L. Kokkinidis

    Sensitization to amphetamine and tolerance to cocaine and phencyclidine stimulation in mice

    Pharmacol. Biochem. Behav.

    (1986)
  • R.M. Allen et al.

    Phencyclidine-induced psychosis

    Am. J. Psychiatry

    (1978)
  • B.M. Angrist et al.

    The phenomenology of experimentally induced amphetamine psychosis - preliminary observations

    Biol. Psychiatry

    (1970)
  • B.M. Angrist et al.

    The antagonism of amphetamine-induced symptomology by a neuroleptic

    Am. J. Psychiatry

    (1974)
  • O. Aniline et al.

    The urban epidemic of phencyclidine use: laboratory evidence from a public psychiatric hospital service

    Biol. Psychiatry

    (1980)
  • O. Aniline et al.

    Phencyclidine (PCP): a review and perspectives

    CRC Crit. Rev. Toxicol.

    (1982)
  • N.A. Anis et al.

    The effects of optical isomers of ketamine on excitation of cat and rat spinal neurons by amino acids and acetylcholine

    Neurosci. Lett.

    (1983)
  • R. Aronow et al.

    Clinical observations during phencyclidine intoxication and treatment based on ion trapping

    Natl. Inst. Drug Abuse Res. Monogr. Ser.

    (1978)
  • R.S. Aronstam et al.

    Sites of action of phencyclidine, III. Interactions with muscarinic receptors

    Mol. Pharmacol.

    (1980)
  • M.D. Baaker et al.

    Observation on the psychotomimetic effects of Sernyl

    Comprehen. Psychiatry

    (1961)
  • R.J. Baldessarini et al.

    Clozapine. A novel antipsychotic agent

    New Engl. J. Med.

    (1991)
  • R.L. Balster

    Clinical implications of behavioral pharmacology research on phencyclidine

    Natl. Inst. Drug Abuse Res. Monogr. Ser.

    (1986)
  • R.L. Balster

    The behavioral pharmacology of phencyclidine

  • R.L. Balster et al.

    The behavioral pharmacology of phencyclidine

    Clin. Toxicol.

    (1976)
  • U. Banerjee et al.

    Time related interaction patterns of amphetamine with reserpine and other central depressants

    Res. Commun. Chem. Pathol. Pharmacol.

    (1973)
  • P.M. Beardsley et al.

    Evaluation of antagonists of the discriminitive stimulus and response rate effects of phencyclidine

    J. Pharmacol. Exp. Ther.

    (1988)
  • R. Bederka et al.

    Neurosci. Abstr.

    (1975)
  • D.S. Bell

    Comparison of amphetamine psychosis and schizphrenia

    Am. J. Psychiatry

    (1965)
  • M.J. Brocco et al.

    The effects of chronic phencyclidine administration on the scheduled behavior of rats

    J. Exp. Ther.

    (1983)
  • R.G. Browne

    Discriminative stimulus properties of PCP mimetics

    Natl. Inst. Drug Abuse Res. Monogr. Ser.

    (1986)
  • M.S. Buchsbaum
  • S.R. Burns et al.

    Phencyclidine: an emerging drug problem

    Clin. Toxicol.

    (1976)
  • S.R. Burns et al.

    Phencyclidine deaths

    J. Am. Coll. Phys.

    (1978)
  • S.R. Burns et al.

    Phencyclidine states of acute intoxication and fatalities

    West. J. Med.

    (1975)
  • L.D. Byrd

    Comparison of the behavioral effects of phencyclidine, ketamine, d-amphetamine and morphine in the squirrel monkey

    J. Pharmacol. Exp. Ther.

    (1982)
  • A. Carlsson

    Antipsychotic drugs, neurotransmitters, and schizophrenia

    Am. J. Psychiatry

    (1978)
  • A. Carlsson et al.

    Effects of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain

    Acta Pharmacol.

    (1963)
  • M.E. Carroll et al.

    Oral d-amphetamine and ketamine self-administration by rhesus monkeys: effects of food deprivation

    J. Pharmacol. Exp. Ther.

    (1983)
  • S. Castellani et al.

    Effects of naloxone, metenkephalin, and morphine-induced behavior in the rat

    Psychopharmacology

    (1982)
  • Cited by (0)

    View full text